Effects of nateglinide on the elevation of postprandial remnant-like particle triglyceride levels in Japanese patients with type 2 diabetes assessment by meal tolerance test

Endocrine

Volumn 25, Issue 3, 2004, Pages 203-206

  Mori, Yutaka ^a   Kuriyama, Genshin ^a   Tajima, Naoko ^b  

^a Kawachi gun   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Meal tolerance test; Nateglinide; Postprandial hyperlipidemia; Remnant like particle (RLP) triglyceride; Type 2 diabetes

Indexed keywords

NATEGLINIDE; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; CHOLESTEROL; CYCLOHEXANE DERIVATIVE; DRUG DERIVATIVE; INSULIN; LIPOPROTEIN; PHENYLALANINE; REMNANT LIKE PARTICLE CHOLESTEROL; REMNANT-LIKE PARTICLE CHOLESTEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DIET THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; INSULIN RESPONSE; LIPID METABOLISM; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HYPERGLYCEMIA; JAPAN; METABOLISM; MIDDLE AGED;

BLOOD GLUCOSE; CHOLESTEROL; CYCLOHEXANES; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; JAPAN; LIPOPROTEINS; MIDDLE AGED; PHENYLALANINE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 22244491288     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:25:3:203     Document Type: Article

References (22)

1. The DECODE Study Group. European Diabetes Epidemiology Group. (1999). Lancet 354, 617-621.
2. DECODE Study Group, the European Diabetes Epidemiology Group. (2001). Arch. Intern. Med. 161, 397-405.
3. Teno, S., Uto, Y., Nagashima, H., et al. (2000). Diabetes Care 23, 1401-1406.
4. Ross, R. (1993). Nature 362, 801-809.
5. Ceriello, A., Taboga, C., Tonutti, L., et al. (2002). Circulation 106, 1211-1218.
6. Tanaka, A., Tomie, N., Nakano, T., et al. (1998). Clin. Chim. Acta 275, 43-52.
7. Ai, M., Tanaka, A., Ogita, K., et al. (2000). J. Clin. Endocrinol. Metab. 85, 3557-3560.
8. Ai, M., Tanaka, A., Ogita, K., et al. (2001). J. Am. Coll. Cardiol. 38, 1628-1632.
9. McNamara, J. R., Shah, P. K., Nakajima, K., et al. (2001). Atherosclerosis 154, 229-236.
10. Kugiyama, K., Doi, H., Takazoe, K., et al. (1999). Circulation 99, 2858-2860.
11. Schaefer, E. J., McNamara, J. R., Shah, P. K., et al. (2002). Diabetes Care 25, 989-994.
12. Horton, E. S., Clinkingbeard, C., Gatlin, M., Foley, J., Mallows, S., and Shen, S. (2000). Diabetes Care 23, 1660-1665.
13. Mine, T., Miura, K., Kitahara, Y., Okano, A,. and Kawamori, R. (2002). Biol. Pharm. Bull. 25, 1414-1416.
14. Esposito, K., Giugliano, D., Nappo, F., Marfella, R., and Campanian Postprandial Hyperglycemia Study Group. (2004). Circulation 110, 214-219.
15. Vakkilainen, J., Mero, N., Schweizer, A., Foley, J. E., and Taskinen, M.-R. (2002). Diabetes Metab. Res. Rev. 18, 484-490.
16. Mori, Y., Kitahara, Y., Miura, K., Mine, T., and Tajima, N. (2004). Diabetes Obes. Metab. 6, 422-431.
17. Mori, Y., Kitahara, Y., Miura, K., and Tajima, N. (2004). Endocrine 23, 39-44.
18. Dimitriadis, G., Boutati, E., Lambadiari, V., et al. (2004). Eur. J. Clin. Invest. 34, 490-497.
19. Califf, R. M. (2003). Eur. Heart J. Suppl. 5(Suppl C), C13-C18.
20. Ogawa, S., Takeuchi, K., Sugimura, K., et al. (2000). Metabolism 49, 331-334.
21. Banauch, D., Brummer, W., Ebeling, W., et al. (1975). Z. Klin. Chem. Klin. Biochem. 13, 101-107.
22. Nakajima, K., Saito, T., Tamura, A., et al. (1993). Clin. Chim. Acta 223, 53-71.